搜尋
Scienture Holdings Inc
SCNX添加自選
0.290USD
+0.005+1.75%
收盤 09-23 16:00（美東）
11.78M總市值
虧損本益比TTM
關於 Scienture Holdings Inc 公司
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
Scienture Holdings Inc 簡介
公司代碼SCNX
公司名稱Scienture Holdings Inc
上市日期Feb 18, 2020
CEOHariharan (Shankar)
員工數量14
證券類型Ordinary Share
年結日Feb 18
公司地址- -
城市- -
上市交易所NASDAQ OMX - NASDAQ BASIC
國家- -
郵編- -
電話- -
網址- -
公司代碼SCNX
上市日期Feb 18, 2020
CEOHariharan (Shankar)
Scienture Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
2.95M
+64.35%
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
2.95M
+64.35%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
2.95M
+64.35%
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
2.95M
+64.35%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
常見問題
Scienture Holdings Inc的前五大股東是誰？
Scienture Holdings Inc的前五大股東如下：Dr. Narasimhan Mani
有多少機構持有Scienture Holdings Inc(SCNX)的股份？
截至2026Q1，共有26家機構持有Scienture Holdings Inc的股份，合計持有的股份價值約為2.00M，占公司總股份的4.93% 。與2025Q4相比，機構持股有所增加，增幅為289959.00。